UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

Cancer cell, 2019-05, Vol.35 (5), p.721-737.e9

2019

Volltextzugriff (PDF)

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma

Blood, 2017-08, Vol.130 (8), p.995-1006

2017

Volltextzugriff (PDF)

Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10), p.2721-2731

2018

Volltextzugriff (PDF)

Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML

Leukemia, 2021-09, Vol.35 (9), p.2469-2481

2021

Volltextzugriff (PDF)

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer discovery, 2020-03, Vol.10 (3), p.440-459

2020

Volltextzugriff (PDF)

Detecting Förster resonance energy transfer in living cells by conventional and spectral flow cytometry

Cytometry. Part A, 2022-10, Vol.101 (10), p.818-834

2022

Volltextzugriff (PDF)

Genome variation and conserved regulation identify genomic regions responsible for strain specific phenotypes in rat

BMC genomics, 2017-12, Vol.18 (1), p.986-986, Article 986

2017

Volltextzugriff (PDF)

Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat

PloS one, 2017-08, Vol.12 (8), p.e0182650-e0182650

2017

Volltextzugriff (PDF)

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of clinical oncology, 2023-02, Vol.41 (4), p.745-755

2023

Volltextzugriff (PDF)

Independent and Pleiotropic Gene Effects on Hypertension and Metabolic Syndrome in Lyon Hypertensive Rats

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Volltextzugriff (PDF)

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

Blood advances, 2022-02, Vol.6 (4), p.1143-1151

2022

Volltextzugriff (PDF)

Genomic structure of nucleotide diversity among Lyon rat models of metabolic syndrome

BMC genomics, 2014-03, Vol.15 (1), p.197-197, Article 197

2014

Volltextzugriff (PDF)

Abstract 2720: Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2720-2720

2019

Volltextzugriff (PDF)

Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7519-7519

2017

Volltextzugriff (PDF)

Systems biology with high-throughput sequencing reveals genetic mechanisms underlying the metabolic syndrome in the Lyon hypertensive rat

Circulation. Cardiovascular genetics, 2015-04, Vol.8 (2), p.316

2015

Volltextzugriff (PDF)

MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models

Clinical lymphoma, myeloma and leukemia, 2017-10, Vol.17 (10), p.S2-S2

2017

Volltextzugriff (PDF)

Upregulation of MCL-1 through MAPK Activation Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Clinical lymphoma, myeloma and leukemia, 2017-09, Vol.17, p.S285-S285

2017

Volltextzugriff (PDF)

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Blood, 2018-11, Vol.132 (Supplement 1), p.3488-3488

2018

Volltextzugriff (PDF)

Inhibition of Translation Initiation and Heat Shock Factor 1 (HSF1): A Novel Strategy Targeting FLT3 Double Mutant and Non-FLT3 Mutant AML Progenitor/Stem Cells

Blood, 2017-12, Vol.130, p.2637-2637

2017

Volltextzugriff (PDF)

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Blood, 2017-12, Vol.130, p.414-414

2017

Volltextzugriff (PDF)

Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Blood, 2016-12, Vol.128 (22), p.101-101

2016

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(33)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(6)
Bmc Genomics
(2)
Cancer Research
(2)
Clinical Lymphoma, Myeloma And Leukemia
(2)
Journal Of Clinical Oncology
(2)
Acs Central Science
(1)
Blood Advances
(1)
Blood Cancer Discovery
(1)
Cancer Cell
(1)
Cancer Discovery
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma

Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

Detecting Förster resonance energy transfer in living cells by conventional and spectral flow cytometry

Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat

Genome variation and conserved regulation identify genomic regions responsible for strain specific phenotypes in rat

Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Independent and Pleiotropic Gene Effects on Hypertension and Metabolic Syndrome in Lyon Hypertensive Rats

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

Genomic structure of nucleotide diversity among Lyon rat models of metabolic syndrome

Abstract 2720: Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study

Systems biology with high-throughput sequencing reveals genetic mechanisms underlying the metabolic syndrome in the Lyon hypertensive rat

MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models

Upregulation of MCL-1 through MAPK Activation Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Inhibition of Translation Initiation and Heat Shock Factor 1 (HSF1): A Novel Strategy Targeting FLT3 Double Mutant and Non-FLT3 Mutant AML Progenitor/Stem Cells

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML

Suchergebnisse filtern